Home > Food, Nutrition & Animal Feed > Chondroitin Sulfate Market
Chondroitin Sulfate Market size is poised to grow with a lucrative CAGR from 2023 to 2032, driven by the growing prevalence of osteoarthritis worldwide.
As per the Centers for Disease Control & Prevention (CDC), in the U.S., osteoarthritis affects approximately 32.5 million individuals. Chondroitin supplements are widely recommended to patients with osteoarthritis for better pain management. Chondroitin sulfate helps patients by slowing down the degeneration of cartilage in joints which results in arthritis-related pain.
European Medicines Agency considers chondroitin sulfate an effective anti-osteoarthritis drug, while the U.S. Food and Drug Administration (FDA) regulates the compound as a dietary supplement enabling access to adequate supplementation. Chondroitin sulfate is popularly used by the American population as a joint health supplement owing to its clinically proven effectiveness in treating osteoarthritis. It also finds significant use in the field of sports and fitness nutrition to address sports-related injuries.
Growing disposable income and increasing pet adoption rates across developed countries are accelerating the penetration of chondroitin sulfate in the pet food sector. A large number of pet parents are spending heavily in high quality pet foods to ensure better health. For instance, according to the 2022 PAW report from the People’s Dispensary for Sick Animals (PDSA), dry food accounts for 39% of dog food followed by a mix of wet and dry food at 35%.
While the growing consumer interest in health and hygiene spurred the chondroitin sulfate market applications in pet food, animal feed, dietary supplements, and pharmaceutical sectors, the COVID-19 pandemic introduced significant supply chain disruptions. Furthermore, the impact of the Russia-Ukraine war on global trade and inflation is set to impact the industry outlook adversely.
Based on source, bovine-sourced chondroitin sulfate market is estimated to record tremendous growth over 2032, owing to the growing demand for nutraceuticals and pharmaceuticals. The growing limitations associated with shark cartilage supplements are expected to foster the production of bovine-sourced chondroitin sulfate. The majority of the manufacturers use chondroitin sourced from cow trachea.
In terms of application, the animal feed sector is anticipated to increase significantly by 2032. Chondroitin sulfate offers a myriad of benefits in pet food and veterinary supplement production with its excellent shock absorption and water retention properties. It also elevates the nutritional profile of bioactive supplements and helps boost activity and joint mobility in pets. The rising incidence rate of degenerative bone disorders in animals is expected to drive the demand for chondroitin sulfate supplements.
North America chondroitin sulfate market size is predicted to register notable expansion between 2023 and 2032, propelled by the extensive R&D and investments in the pharmaceutical sector. North America is home to leading pharma giants enhancing research and innovation in dietary supplements and other products for better health performance. Favorable government initiatives pertaining to healthcare infrastructure development and increasing product approvals by the U.S. FDA will complement the industry growth.
Some of the leading companies involved in the chondroitin sulfate market include Summit Nutritionals International, Shandong Runxin Biotechnology, TSI Group, Yantai Ruikangda Biochemical Products, Synutra Ingredients, Pacific Rainbow International, Qingdao WanTuMing Biological Products, Sioux Pharm, S.A.U. Seikagaku Corporation, and ZPD A/S.